Page last updated: 2024-10-23

benserazide and Alloxan Diabetes

benserazide has been researched along with Alloxan Diabetes in 4 studies

Benserazide: An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.
benserazide : A carbohydrazide that results from the formal condensation of the carboxy group of DL-serine with the primary amino group of 4-(hydrazinylmethyl)benzene-1,2,3-triol. An aromatic-L-amino-acid decarboxylase inhibitor (DOPA decarboxylase inhibitor) that does not enter the central nervous system, it is used as its hydrochloride salt as an adjunct to levodopa in the treatment of parkinsonism. By preventing the conversion of levodopa to dopamine in the periphery, it causes an increase in the amount of levodopa reaching the central nervous system and so reduces the required dose. Benserazide has no antiparkinson actions when given alone.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamada, J1
Sugimoto, Y1
Ujikawa, M1
Goko, H1
Yagura, T1
Pfeil, K1
Staudacher, T1
Luippold, G1
Furman, BL1
Wilson, GA1
Trulson, ME1
Jacoby, JH1
MacKenzie, RG1

Other Studies

4 other studies available for benserazide and Alloxan Diabetes

ArticleYear
Hyperleptinemia elicited by the 5-HT precursor, 5-hydroxytryptophan in mice: involvement of insulin.
    Life sciences, 2003, Sep-19, Volume: 73, Issue:18

    Topics: 5-Hydroxytryptophan; Adipose Tissue; Animals; Benserazide; Diabetes Mellitus, Experimental; Dose-Res

2003
Effect of L-dopa decarboxylase inhibitor benserazide on renal function in streptozotocin-diabetic rats.
    Kidney & blood pressure research, 2006, Volume: 29, Issue:1

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Diabetes Mellitus, Experimental;

2006
Further studies on the effects of 5-hydroxytryptophan on plasma glucose and insulin in the mouse.
    Diabetologia, 1980, Volume: 19, Issue:4

    Topics: 5-Hydroxytryptophan; Animals; Benserazide; Blood Glucose; Diabetes Mellitus, Experimental; Insulin;

1980
Streptozotocin-induced diabetes reduces brain serotonin synthesis in rats.
    Journal of neurochemistry, 1986, Volume: 46, Issue:4

    Topics: 5-Hydroxytryptophan; Animals; Benserazide; Brain; Carboxy-Lyases; Diabetes Mellitus, Experimental; H

1986